No Prescription |
 |
 | ||
|
E Mycin Ery C |
|
| ||
No Prescription » Prescription Drugs 6 » E Mycin Ery C Erythromycin is an antibiotic used to treat certain infections caused by bacteria such as bronchitis; diphtheria; Legionnaires' disease; pertussis (whooping cough); pneumonia; rheumatic fever; venereal disease (VD); and ear intestine lung urinary tract and skin infections. It is also used before some surgery or dental work to prevent infection. Antibiotics will not work for colds flu or other viral infections.Erythromycin comes as a capsule tablet long-acting capsule long-acting tablet chewable tablet liquid and pediatric drops to take by mouth. It usually is taken every 6 hours (four times a day) or every 8 hours (three times a day) for 7-21 days. Some infections may require a longer time. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take erythromycin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Shake the liquid and pediatric drops well before each use to mix the medication evenly. Use the bottle dropper to measure the dose of pediatric drops.The chewable tablets should be crushed or chewed thoroughly before they are swallowed. The other capsules and tablets should be swallowed whole and taken with a full glass of water. Buy E Mycin Ery C and other Prescription Drugs 6 products online at Medstore. 108
About E Mycin Ery C: Product Type: Prescription Drugs 6 E-Mycin ( Ery-C Ery Generic Erythromycin ) E-Mycin (Ery-C Ery Generic Erythromycin) Ery-C Ery Generic Erythromycin 400mg 100 tabs Ery-C Ery Generic Erythromycin E-Mycin
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
